What were Alkem Laboratories Ltd's latest quarterly results?
Alkem Laboratories Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -22.0%
- Revenue Growth YoY: +14.6%
- Operating Margin: 14.0%
Alkem Laboratories Ltd: Stock Analysis & Fundamentals
Updated this weekAlkem Laboratories Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 26.6. ROE: 18.9%. This stock is not currently in the Nifty 500 momentum outperformers list.
Alkem Laboratories Ltd Key Facts
What's Happening
👔Promoter stake down 4.5% this quarter
🏛️DII accumulation — stake up 2.7%
Key Numbers
Current Price
₹5,428
Dividend Yield
0.83%
Market Cap
64.9K Cr
Valuation
N/AOther Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Alkem Laboratories Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Alkem Laboratories Ltd's current PE ratio?
Alkem Laboratories Ltd's current PE ratio is 26.6x.
- Current PE: 26.6x
- Market Cap: 64.9K Cr
- Dividend Yield: 0.83%
What is Alkem Laboratories Ltd's price-to-book ratio?
Alkem Laboratories Ltd's price-to-book ratio is 4.7x.
- Price-to-Book (P/B): 4.7x
- Book Value per Share: ₹1156
- Current Price: ₹5428
Is Alkem Laboratories Ltd a fundamentally strong company?
Alkem Laboratories Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 21.0%
Is Alkem Laboratories Ltd debt free?
Alkem Laboratories Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹2,000 Cr
What is Alkem Laboratories Ltd's return on equity (ROE) and ROCE?
Alkem Laboratories Ltd's return ratios over recent years
- FY2024: ROCE 20.0%
- FY2025: ROCE 20.0%
- FY2026: ROCE 21.0%
Is Alkem Laboratories Ltd's cash flow positive?
Alkem Laboratories Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹2,000 Cr
- Free Cash Flow (FCF): ₹296 Cr
- CFO/PAT Ratio: 83% (strong cash conversion)
What is Alkem Laboratories Ltd's dividend yield?
Alkem Laboratories Ltd's current dividend yield is 0.83%.
- Dividend Yield: 0.83%
- Current Price: ₹5428
Who holds Alkem Laboratories Ltd shares — promoters, FII, DII?
Alkem Laboratories Ltd's shareholding pattern (Mar 2026)
- Promoters: 51.2%
- FII (Foreign): 10.2%
- DII (Domestic): 21.4%
- Public: 17.3%
Is promoter holding increasing or decreasing in Alkem Laboratories Ltd?
Alkem Laboratories Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 51.2% (Mar 2026)
- Previous Quarter: 51.2% (Dec 2025)
- Change: 0.00% (stable)
Is Alkem Laboratories Ltd a new momentum entry or an established outperformer?
Alkem Laboratories Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Alkem Laboratories Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Alkem Laboratories Ltd may be worth studying
- Cash flow is positive — CFO ₹2,000 Cr
What is the investment thesis for Alkem Laboratories Ltd?
Alkem Laboratories Ltd investment thesis summary:
What is the future outlook for Alkem Laboratories Ltd?
Alkem Laboratories Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.